Oxymetholone therapy in patients with familial antithrombin III deficiency. 1988

A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
Division of Hematology, University of Tsukuba, Ibaraki, Japan.

Three patients with familial antithrombin III (ATIII) deficiency, who also have histories of thromboembolism, were treated with oxymetholone in combination with warfarin. Thrombolysis was observed in one patient with acute thrombosis of inferior vena cava during the oxymetholone and warfarin therapy. No further thromboembolic episodes occurred in these patients after initiation of warfarin with or without oxymetholone. The levels of plasma ATIII, alpha 1-antitrypsin, plasminogen and Cl-inactivator were significantly increased in all patients after the introduction of oxymetholone therapy. This suggests that oxymetholone augments anticoagulant and fibinolytic activity. Hence we consider that oxymetholone in combination with warfarin may be possible thrombolytic therapy in patients with familial ATIII deficiency.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010110 Oxymetholone A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed) Hydroxymetholone,Anadrol,Anapolon 50,Oxymethalone,Oxymetholone, (17 beta)-Isomer,Oxymetholone, (5 alpha,17 alpha)-Isomer
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
January 1990, Clinical and laboratory haematology,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
July 1984, British journal of haematology,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
January 1982, The Quarterly journal of medicine,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
January 1982, Sangre,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
June 1985, The New Zealand medical journal,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
February 1978, British medical journal,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
May 1983, Lancet (London, England),
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
January 1988, Pediatriia,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
January 1981, Ugeskrift for laeger,
A Shibuya, and H Ninomiya, and M Nakazawa, and T Nagasawa, and Y Yoda, and T Abe
February 1980, Scandinavian journal of haematology,
Copied contents to your clipboard!